๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Langerhans cell histiocytosis in the adult

โœ Scribed by Malpas, J. S.; Norton, A. J.


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
532 KB
Volume
27
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


A study of 47 well-documented patients with Langerhans cell histiocytosis (LCH) showed a slight female preponderance, with onset as late as the ninth decade. The skin was the commonest site of presentation, but pulmonary and bone involvement was frequent. Patients with single-site disease did best. The worst prognosis was seen in the elderly or those with organ dysfunction. A high incidence of associated malignant disease was seen, which could precede, be coincidental with, or occur after a diagnosis of LCH.


๐Ÿ“œ SIMILAR VOLUMES


Langerhans'-cell histiocytosis in adults
โœ Baumgartner, Iris; von Hochstetter, Arthur; Baumert, Brigitta; Luetolf, Urs; Fol ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 197 KB ๐Ÿ‘ 1 views

Guided by a long-term retrospective observa-bone lesions (n ฯญ 27), which remained asymption, the clinical course and treatment of Langer-tomatic or showed a remission to treatment, hans'-cell histiocytosis (LCH) in adult patients multifocal LCH had a more aggressive course. are represented. The seri

Precursor langerhans cell histiocytosis
โœ Glenn H. Segal; M. Vincent Mesa; Andrew J. Fishleder; Mark H. Stoler; James K. W ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 855 KB
THE PRESENCE OF CYTOKINES IN LANGERHANS'
โœ DE GRAAF, JAN H.; TAMMINGA, RIENK Y. J.; DAM-MEIRING, ANKE; KAMPS, WILLEM A.; TI ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 788 KB

Langerhans' cell histiocytosis (LCH) is characterized by an accumulation and/or proliferation of cells with a Langerhans' cell (LC) phenotype. The aetiology and pathogenesis of LCH are unknown; it is suggested that LCH is caused by an immunological dysregulation. Production of cytokines is a central

Use of indomethacin in Langerhans cell h
โœ Munn, Stephanie E.; Olliver, Lucy; Broadbent, Valerie; Pritchard, Jon ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB ๐Ÿ‘ 2 views

Background. Because prostaglandin (PG) E2 has been identified in the bone lesions of Langerhans cell histiocytosis (LCH), we speculated that indomethacin, a potent PG inhibitor, may be useful in patients with symptomatic LCH involving the bony skeleton. Procedure. We used indomethacin to treat patie

Ear involvement in childhood Langerhans'
โœ Giammarco Surico; Paola Muggeo; Vito Muggeo; Valeria Conti; Chiara Novielli; Ann ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB ๐Ÿ‘ 2 views

Background. Ear involvement (EI) in Langerhans' cell histiocytosis (LCH) occurs quite often. We reviewed the Italian pediatric population of 251 children with LCH diagnosed between 1982 and 1995, focusing on EI, to highlight the prevalence, the clinical presentation, the outcome during follow-up, an